CAPR

Capricor Therapeutics, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Nippon Shinyaku Co Ltd10 Percent Owner
$15M2.8M shares
BuySep 20, 2024
$5.36
--
Bergmann AnthonyCHIEF FINANCIAL OFFICER
$753k25k shares
SellMar 31, 2026
$30.13
--
Sabar Karimah EsDirector
$1.7M53.7k shares
SellApr 1, 2026
$31.03
--
Sabar Karimah EsDirector
$1.8M61.3k shares
SellMar 31, 2026
$30.17
--
Krasney KarenEVP, GENERAL COUNSEL
$753k25k shares
SellMar 31, 2026
$30.12
--
Sabar Karimah EsDirector
$241k7.5k shares
SellApr 2, 2026
$32.00
--

News

globenewswire.comCapricor Therapeutics to Present at Upcoming Investor Conferencesglobenewswire.comJun 8seekingalpha.comCapricor: I Rate It A Buy After Stress-Testing The Sell Thesisseekingalpha.comJun 3seekingalpha.comCapricor Therapeutics, Inc. (CAPR) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 12marketbeat.comCapricor Therapeutics Q1 Earnings Call Highlightsmarketbeat.comMay 12globenewswire.comCapricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updateglobenewswire.comMay 12